Thymogen 10mg
Synthetic thymic dipeptide researched for its configuration-dependent immunomodulatory and bone marrow regenerative properties.
Mechanism
Thymogen operates as a stereospecific dipeptide that modulates cellular immunity and accelerates hematopoietic regeneration within bone marrow microenvironments.
Dosing
The documented reference starting dose in historical literature is approximately 100 mcg administered once daily over a short experimental window of 3 to 10 days.
Reconstitution
Reconstituting a 10 mg vial with 2 mL of bacteriostatic water results in a final concentration of 5 mg/mL.
Storage
Store the unmixed lyophilized powder refrigerated protected from light, and maintain the reconstituted liquid between 2 and 8 °C without freezing.
Mix & measure Thymogen 10mg
Pre-filled with this protocol's recommended BAC water and documented starting dose — edit any field to run your own numbers.
Mix & measure Thymogen 10mg
Vial strength → BAC water → target dose
Common vial sizes
Label claim
Total doses in vial: 100.0
U-100 syringe: 100 units = 1 mL
Need supplies for this protocol?
Research-grade peptides, fast shipping, competitive pricing
Reconstitution math only — not dosing advice. U-100 syringe: 100 units = 1 mL. Advanced calculator →
Track my protocol
Log each dose, build a streak, and watch your progress through this protocol's schedule.
Dosing Chart
| Phase / Day(s) | Dose & Frequency | Volume (U-100 units / mL) |
|---|---|---|
| Clinical-Equivalent Reference | 100 mcg daily | 0.02 mL (2 units) |
| Intermediate Research Level | 250 mcg daily | 0.05 mL (5 units) |
| High Experimental Benchmark | 1 mg single point | 0.20 mL (20 units) |
| Complete Vial Reference | 10 mg total capacity | 2.00 mL (200 units) |
Reconstitution Steps
- 1
Clean the rubber stoppers of both the Thymogen vial and the bacteriostatic water vial using sterile alcohol prep pads and allow them to air-dry completely.
- 2
Draw 2 mL of bacteriostatic water using an appropriate reconstitution syringe.
- 3
Carefully introduce the needle into the peptide vial, allowing the diluent to run gently down the inside glass wall to avoid foaming the dipeptide cake.
- 4
Swirl the vial gently or roll it smoothly between your palms until the powder dissolves fully into a clear liquid; never shake the solution vigorously.
- 5
Inspect visually for any signs of residual particulate matter or discoloration, then place the solution into refrigerated storage at 2–8 °C.
Supplies Needed
Peptide Vial
Contains 10 mg of lyophilized Thymogen dipeptide for laboratory reconstitution.
Insulin Syringes (U-100)
Used to precisely draw low microgram-equivalent volumes (such as 0.02 mL / 2 units).
Bacteriostatic Water
Sterile diluent containing 0.9% benzyl alcohol required to reconstitute the lyophilized powder.
Alcohol Swabs
Used to sanitize vial stoppers and work surfaces prior to dilution and fluid transfers.
Why researchers study it
Thymic-mediated immunomodulation
Hematopoietic regeneration in irradiated marrow
Configuration-dependent peptide bioregulation
Microgram-range low-concentration biological activity
These describe what is being studied, not proven benefits, approved uses, or promised results.
Overview
Thymogen is a synthetic dipeptide composed of alpha-L-glutamyl-L-tryptophan (Glu-Trp). Originally synthesized as part of the Russian peptide bioregulator initiative, it was designed to emulate the immunoregulatory signaling pathways naturally regulated by the thymus gland. The molecule serves as an ultra-low-molecular-weight analog to complex organ extracts such as Thymalin, providing a streamlined tool for investigating cellular immune responses in laboratory models. Crucially, experimental protocols must differentiate Thymogen from golotimod (SCV-07), which features a gamma-D-Glu-L-Trp stereo-orientation. Pharmacological studies demonstrate that the specific optical isomerism governs its biological activity, meaning findings from D-isomer analogs cannot be translated to Thymogen research. While authorized within Russia for clinical use, it remains strictly an unapproved experimental bioregulator across Western regulatory domains. Investigational designs emphasize microgram-level interactions rather than standard milligram regimes. A standard 10 mg research vial contains numerous experimental single doses, requiring precise dilution protocols to ensure volumetric accuracy during testing in cell cultures or animal models.
References
- 1.Deigin et al., Immunology Letters, 1999 — Reciprocal effect of optical isomerism of EW-dipeptides on immune response
- 2.Okovityi & Gaivoronskaya, Eksperimental’naya i Klinicheskaya Farmakologiya, 2002 — Immune mechanisms of hepatoprotector effects of etomerzol and thymogen
- 3.Khavinson, Kuznik & Ryzhak, Advances in Gerontology, 2013 — Peptide bioregulators: a new class of geroprotectors (clinical studies results)
- 4.Khavinson et al., Molecules, 2020 — Peptides: prospects for use in the treatment of COVID-19
Supplies Needed
Suggested supplier
Research use only. Listing a supplier is not an endorsement of any protocol on this site, and nothing sold there is approved for human use.
Related protocols
View allGonadorelin 2mg
Synthetic GnRH decapeptide investigated for anterior pituitary gonadotropin stimulation and HPG axis regulation in research models.
View ProtocolAOD-9604 2mg
Synthetic C-terminal fragment of human growth hormone (176–191) investigated for fat metabolism and lipolytic pathways.
View ProtocolHumanin 5mg
Mitochondrial-derived peptide and potent HNG analog researched for cellular survival, metabolic signaling, and cytoprotective pathways.
View Protocol